Diana Sherifali & Megan Racey on type 2 diabetes remission, Vivian Fonseca on inadequately controlled t2d and hypercortisolism, and more!

Welcome to episode no. 40 (December 2025) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the December 2025 issue of Diabetes Care and beyond.

4:10 Alice is joined by Diana T. Sherifali, PhD, BScN, Professor in the School of Nursing at McMaster University and lead of the McMaster Evidence Review & Synthesis Team (MERST), as well as Megan Racey, PhD, Senior Research Coordinator at MERST. Their article, "Type 2 Diabetes Remission: A Systematic Review and Meta-analysis of Nonsurgical Randomized Controlled Trials," is available for free at doi.org/10.2337/dc25-0562

22:25 Mike speaks with Vivian A. Fonseca, MD, FRCP, Assistant Dean for Clinical Research at the Tulane University School of Medicine. His article, "Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment," is available for free at doi.org/10.2337/dc25-1055.

38:35 In the "Diabetes Care Rapid Exchange," Alice and Mike wrap up the episode by reviewing several interesting articles in the December 2025 issue of Diabetes Care. Studies highlighted in this segment include:

• Becker et al. Familial Hypercholesterolemia in Pediatric Patients With Type 1 Diabetes: Double Challenge for Diagnosis and Treatment doi.org/10.2337/dc25-1195

• Sacre et al. Incidence of Type 2 Diabetes With Verapamil Compared With Other Calcium Channel Blockers doi.org/10.2337/dc25-1440

• Wang et al. Response to Comment on Wang et al. Transition of BMI Status From Childhood to Adulthood and Cardiovascular-Kidney-Metabolic Syndrome in Midlife: A 36-Year Cohort Study. Diabetes Care 2025;48:2045–2053 doi.org/10.2337/dci25-0102

• Hirsch et al. Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level doi.org/10.2337/dc25-1125

• Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure doi.org/10.2337/dc25-1260

• Fang et al. Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes doi.org/10.2337/dc25-1840

To learn more about Diabetes Care, please visit diabetesjournals.org/care. Interested in submitting cover art to the journal? Please visit https://diabetesjournals.org/care/pages/submit_a_cover_image.